GPT and fatty liver disease: Previously, Sharifi et al. [39] investigated the effect of twice a month 16-week cholecalciferol supplementation on aminotransferases, insulin resistance and inflammatory profile in non-diabetic subjects selected on the basis of US-detected fatty liver and upper-than-normal ALT levels, but no effects were shown compared to placebo.